Answers are grounded in this paper and cite their sources.
Exercise is a cornerstone therapy for diabetes because working skeletal muscles take up glucose at dramatically greater rates than postprandial uptake and, notably, do so without a requirement for insulin. Insulin- in dependent glucose uptake operates normally during exercise and other conditions when adrenergic stimulation inhibits pancreatic insulin release, and it provides a means of glucose disposal in insulin resistant conditions. However, the mechanisms of insulin-independent glucose uptake are not fully understood. Here, we describe a previously unrecognized glucose uptake pathway in muscle, which we refer to as mSGLT based on shared properties with the sodium/glucose cotransporter family (SGLT/ Slc5a ). In contrast to the abundant muscle GLUT4 transporter, mSGLT activity is not regulated by insulin, requires Na,K-ATPase-α2 activity, and transports the hexose α-methyl-D-glucoside (αMDG), a glucose derivative that is handled by SGLTs but not GLUT4. mSGLT shares antigenicity with the kidney SGLT2 and localizes to the muscle t-tubules together with Na,K-ATPase-α2 and MAP17, the regulatory subunit of SGLT2. Skeletal muscles do not express a full-length transcript of Slc5a2 , and mSGLT shows weak affinity for SGLT2-specific inhibitors. mSGLT may be a muscle SGLT isoform. mSGLT and its regulation offer potential muscle-specific targets for treating hyperglycemia and conditions when insulin-stimulated glucose disposal into muscle is impaired.
No takes yet. Share an insight, caveat, or question.
Norman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: